Preclinical evaluation of heat-denatured [18F]FDG-labeled red blood cells for detecting splenic tissues with PET in rats
Preclinical evaluation of heat-denatured [18F]FDG-labeled red blood cells for detecting splenic tissues with PET in rats
复制标题
DOI:
10.1016/j.nucmedbio.2017.09.002
复制
发表时间:
2018-01-01
影响因子:
3.1
通讯作者:
Jinzaki, Masahiro
中科院分区:
文献类型:
--
作者:
Matsusaka, Yohji;Nakahara, Tadaki;Jinzaki, Masahiro
Introduction: Heat-denatured Tc-99m-labeled red blood cells (RBCs) are used for detecting splenic tissues with scintigraphy. The present study aimed to evaluate the feasibility of using heat-denatured [F-18]fluorodeoxyglucose ([F-18] FDG)-labeled RBCs in detecting splenic tissues using positron emission tomography (PET) in rats.Methods: RBCs were washed with phosphate buffered saline, labeled with [F-18]FDG at 38 degrees C, and heat-denatured at 50 degrees C for 15 min. In vitro stability was assessed by measuring extracellular radioactivity during the 0-180 min incubation at 37 degrees C. Thin layer chromatography (TLC) of the extracellular fluid was performed. The autologous RBCs were intravenously injected in four rats and PET scanning was simultaneously performed for 30 min. Time-activity curves of several organs, including the spleen, were analyzed on the PET images.Results: Labeling efficiency was 92%. Low levels of radioactivity were released from the labeled RBCs for 180 min. TLC revealed that 80% of the released radioactivity was due to [F-18]DG-6-phosphate. Whole body images showed strong uptake of heat-denatured [F-18]FDG-labeled RBC5 in the spleen soon after injection in all four rats. Time activity curves revealed that the splenic uptake continued to increase for 30 min and the amount of radioactivity in the other organs, except the urinary bladder, decreased after the initial surge.Conclusions: Heat-denatured [F-18]FDG-labeled RBCs are suitable spleen-specific agents for PET. This method is clinically relevant as an alternative for heat-denatured Tc-99m-labeled RBC scintigraphy. (C) 2017 Elsevier Inc. All rights reserved.